Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Research and Care Networks in Acute Leukemia As a Model for Global Healthcare Collaboration

Martin R Guscott, Stacy L Cooper, Poonam Bagai, Archie Bleyer, Randal K Buddington, Dan Douer, Tina B Chong, Ryan R Combs, Jennifer L Hylton, Gabriela Ines-Villanueva, Jennifer A Lowe, Rishabh Pandey, Aman N Patel, Scott C Howard

Blood (2021) 138 (Supplement 1): 4966.

https://doi.org/10.1182/blood-2021-147876

Published: 2021

Journal Articles

Disparities in Cancer-Related Mortality and Long-Term Survival in Adolescent and Young Adults with Hodgkin Lymphoma: A Population-Level Analysis across the United States

Justine M. Kahn, MD MSc, Theresa H.M. Keegan, PhD MS, Elysia Alvarez, MD MPH, Lori S Muffly, MD, Helen Parsons, Lena E. Winestone, MD, Archie Bleyer, MD

Blood (2018) 132 (Supplement 1): 4866.

https://doi.org/10.1182/blood-2018-99-119382

Published: 2018

Journal Articles

Anti-Pegaspargase, Anti-Calaspargase Pegol , and Anti-Polyethelene Glycol Antibody Incidence in High Risk Acute Lymphoblastic Leukemia Patients Receiving Pegaspargase or Calaspargase Pegol and Associated Anaphylactic or Hypersensitivity Reaction Rates: Results from Children's Oncology Group (COG) Study AALL07P4

Reuven J Schore, MD, Meenakshi Devidas, PhD, Archie Bleyer, MD, Gregory Reaman, MD, Claudia Lebedinsky, MD, Hui Zhang, MS, Herwig Koppensteiner, PhD, Mignon L. Loh, MD, Elizabeth Raetz, MD, Naomi Winick, MD, William L. Carroll, MD, Stephen P. Hunger, MD, Anne Angiolillo, MD

Blood (2016) 128 (22): 3965.

https://doi.org/10.1182/blood.V128.22.3965.3965

Published: 2016

Journal Articles

Young adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen do not need a bone marrow transplant in first remission

Michael S. Isakoff, David R. Freyer, Archie Bleyer

Blood (2013) 121 (26): 5253–5255.

https://doi.org/10.1182/blood-2013-03-484592

Published: 2013

Journal Articles

Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial

Linda C. Stork, Yousif Matloub, Emmett Broxson, Mei La, Rochelle Yanofsky, Harland Sather, Ray Hutchinson, Nyla A. Heerema, April D. Sorrell, Margaret Masterson, Archie Bleyer, Paul S. Gaynon

Blood (2010) 115 (14): 2740–2748.

https://doi.org/10.1182/blood-2009-07-230656

Published: 2010

Journal Articles

Toxicities in Adults with Acute Lymphoblastic Leukemia (ALL) Treated with Regimens Using Pegasparaginase.

Michael Rytting, M.D., Marc Earl, PharmD, Dan Douer, MD, Brenda Muriera, RN, Anjali Advani, MD, Archie Bleyer, MD

Blood (2008) 112 (11): 1924.

https://doi.org/10.1182/blood.V112.11.1924.1924

Published: 2008

Journal Articles

Toxicities of Intravenous (IV) Pegasparaginase (ONCASPAR®) in Adults with Acute Lymphoblastic Leukemia (ALL).

Anjali Advani, MD, Marc Earl, PharmD, Dan Douer, MD, Michael Rytting, MD, Archie Bleyer, MD

Blood (2007) 110 (11): 2811.

https://doi.org/10.1182/blood.V110.11.2811.2811

Published: 2007

Journal Articles

The Racial Disparity Gap in Pediatric Leukemia and Lymphoma Survival Has Been Eliminated in Children but Not in Older Adolescents and Young Adults.

Aaron Viny, BS, Joanne M. Hilden, MD, Anthony Stallion, MD, W. Archie Bleyer, MD

Blood (2006) 108 (11): 76.

https://doi.org/10.1182/blood.V108.11.76.76

Published: 2006

Journal Articles

Results of a Phase II Study of 506U78 (Nelarabine) in Refractory Indolent B-Cell or Peripheral T-Cell Lymphoma.

Michael A. Thompson, MD, PhD, Barbara Pro, MD, Andreas Sarris, MD, PhD, Fredrick B. Hagemeister, MD, Andre Goy, MD, Archie Bleyer, MD, Fernando F. Cabanillas, MD, Felipe Samaniego, MD, MPH, Luis E. Fayad, MD

Blood (2005) 106 (11): 2681.

https://doi.org/10.1182/blood.V106.11.2681.2681

Published: 2005

Journal Articles

Phase II Study of Oxaliplatin in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma: Final Results.

Yasuhiro Oki, M.D., Peter McLauhlin, M.D., Barbara Pro, M.D., Frederick H. Hagemeister, M.D., Archie Bleyer, M.D., Evelyn Loyer, M.D., Anas Younes, M.D.

Blood (2004) 104 (11): 2494.

https://doi.org/10.1182/blood.V104.11.2494.2494

Published: 2004

Journal Articles

Obesity and Body Weight Independently Predict Relapse and Survival in Preadolescents and Teenagers with Acute Lymphoblastic Leukemia (ALL). A Retrospective Analysis of Five Children Cancer Group (CCG) Studies.

Anna Butturini, MD, Fred Dorey, PhD, Paul Gaynon, MD, Cecilia Fu, MD, Janet Franklin, MD, Stuart Siegel, MD, Nancy Sacks, RN, Nita Siebel, MD, David Henry, MD, Paul Rogers, MD, Beverly Lange, MD, Harland Sather, PhD, Michael Trigg, MD, Archie Bleyer, MD

Blood (2004) 104 (11): 992.

https://doi.org/10.1182/blood.V104.11.992.992

Published: 2004

Journal Articles

Pharmacokinetics and Pharmacodynamics of Oral Methotrexate and Mercaptopurine in Children With Lower Risk Acute Lymphoblastic Leukemia: A Joint Children’s Cancer Group and Pediatric Oncology Branch Study

Frank M. Balis, John S. Holcenberg, David G. Poplack, Jeffrey Ge, Harland N. Sather, Robert F. Murphy, Matthew M. Ames, Mary J. Waskerwitz, David G. Tubergen, Solomon Zimm, Gerald S. Gilchrist, W. Archie Bleyer

Blood (1998) 92 (10): 3569–3577.

https://doi.org/10.1182/blood.V92.10.3569

Published: 1998

NARROW

Research and Care Networks in Acute Leukemia As a Model for Global Healthcare Collaboration

Disparities in Cancer-Related Mortality and Long-Term Survival in Adolescent and Young Adults with Hodgkin Lymphoma: A Population-Level Analysis across the United States

Young adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen do not need a bone marrow transplant in first remission

Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial

Toxicities in Adults with Acute Lymphoblastic Leukemia (ALL) Treated with Regimens Using Pegasparaginase.

Toxicities of Intravenous (IV) Pegasparaginase (ONCASPAR®) in Adults with Acute Lymphoblastic Leukemia (ALL).

The Racial Disparity Gap in Pediatric Leukemia and Lymphoma Survival Has Been Eliminated in Children but Not in Older Adolescents and Young Adults.

Results of a Phase II Study of 506U78 (Nelarabine) in Refractory Indolent B-Cell or Peripheral T-Cell Lymphoma.

Phase II Study of Oxaliplatin in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma: Final Results.

Obesity and Body Weight Independently Predict Relapse and Survival in Preadolescents and Teenagers with Acute Lymphoblastic Leukemia (ALL). A Retrospective Analysis of Five Children Cancer Group (CCG) Studies.

Pharmacokinetics and Pharmacodynamics of Oral Methotrexate and Mercaptopurine in Children With Lower Risk Acute Lymphoblastic Leukemia: A Joint Children’s Cancer Group and Pediatric Oncology Branch Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only